Senior Director Global Omnichannel

Overview

The Senior Director, Global Omnichannel will serve as a critical leader responsible for shaping, scaling, governing and sustaining best-in-class omnichannel capabilities across Alnylam. Reporting to the Vice President of Customer Experience and Innovation, this leader will drive consistency, efficiency, and innovation. This role requires a martech-savvy, strategic leader who thrives in complexity, can lead through influence, and is adept at aligning and balancing priorities to help drive the business.

• Global Vision & Standards: Define and evolve the global omnichannel engagement strategy, operating model, and guiding principles to ensure alignment and scalability across regions.
• Governance & Compliance: Establish enterprise-wide governance frameworks, playbooks, and best practices that ensure quality, consistency, and compliance while allowing for local adaptation.
• Unified Capabilities: Harmonize omnichannel capabilities globally, ensuring a consistent enterprise foundation in partnership with IT using a product development and capability focused approach.
• Data-Driven Excellence: Partner with Data Strategy, Measurement and Advanced Analytics teams to establish global measurement frameworks, define success metrics, and embed data-driven decision-making into omnichannel strategies.
• Change Leadership: Act as a global change agent and SME driving organizational adoption of new ways of working, fostering agility, and creating a culture of experimentation and continuous improvement.
• Cross-Functional Partnership: Collaborate with global marketing, medical, IT, patient services, and regional business units to ensure omnichannel strategies are integrated, customer-centric, and business-aligned.
• Executive Engagement: Communicate strategy, progress, and outcomes to global senior leadership, ensuring transparency and alignment with enterprise priorities.
• People Leadership: Responsible for a high-performing team of experts who manage key omni-channel marketing functions and capabilities.
• External Benchmarking & Thought Leadership: Monitor industry trends and benchmarks, bringing external perspective into the organization.

• Bachelor's degree in Marketing, Business, Communications or related field; advanced degree strongly preferred.
• 12+ years of progressive experience in omnichannel marketing, digital transformation, or customer engagement, with significant global or regional leadership.
• Demonstrated success establishing or leading a COE, capability hub, or global enablement function.
• Proven ability to define and scale global, multi-brand frameworks, playbooks, and standards while enabling local market flexibility.
• Strong background in governance, compliance, and operating model design in a complex, regulated environment (pharma/biotech preferred or other highly regulated industry preferred).
• Track record of leading through influence in a global organization.
• Exceptional communication and relationship-building skills with senior stakeholders across geographies and functions.
• Adept at driving organizational change and cultural transformation, fostering agility and continuous improvement.
• Proven ability to inspire, coach, and develop global teams and communities of practice.
• Deep understanding of customer engagement platforms, digital ecosystems, and omnichannel strategy.
• Proven experience defining, implementing and governing global omnichannel / digital operating models
• Awareness and understanding of key technologies such as Salesforce (Marketing, Data and Health Clouds), Veeva, Drupal, etc.
• Product / capability planning and road mapping experience.
• Strong business acumen, with the ability to connect customer-centric strategies to measurable business outcomes.
• External orientation, staying current on global industry benchmarks, regulatory requirements, and best practices in omnichannel and digital engagement.
• Willingness and ability to travel internationally to support global initiatives.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of…